‘Putting DNA repair on the map’- èßäAV³ÉÈË CEO interviewed by Labiotech 29 May 2019 | Media coverage
BioCentury Emerging Company Profile: èßäAV³ÉÈË â€“ Probing DNA Damage 30 January 2019 | Media coverage
èßäAV³ÉÈË in strong position to accelerate cancer programmes after Arix investment 19 December 2018 | Media coverage
èßäAV³ÉÈË Hooks Novartis & Pfizer In Over-Subscribed £65M Series B Round 19 December 2018 | Media coverage
èßäAV³ÉÈË’s £65m Series B To Spur Development Of DDR Cancer Therapies 23 October 2018 | Media coverage
Interview with èßäAV³ÉÈË’ CEO following Biotech and Money’s Awards 2017 16 November 2017 | Media coverage